Noncommunicable diseases
Diabetes
-
Gene- and cell-based therapy of diabetes: between bench and bedside.
Kofman AV, Kharazova AD, Pinaev GP.
Tsitologiia 2002;44(12):1157-77 -
MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks.
Villemure JF, Abaji C, Cousineau I, Belmaaza A.
Cancer Research 2003 Jun 15; 63(12): 3334-9 -
Diabetes gene therapy: potential and challenges.
Xu R, Li H, Tse LY, Kung HF, Lu H, Lam KS.
Current Gene Therapy 2003 Feb;3(1):65-82 -
Gene- and cell-based therapeutics for type I diabetes mellitus.
Bottino R, Lemarchand P, Trucco M, Giannoukakis N.
Gene Therapy 2003 May;10(10):875-89 -
Regeneration therapy for diabetes mellitus.
Yamaoka T.
Expert Opinion on Biological Therapy 2003 Jun;3(3):425-33 -
A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes.
Li H, Groop L, Nilsson A, Weng J, Tuomi T.
Journal of Clinical Endocrinology and Metabolism2003 Jun;88(6):2767-74. -
Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects.
Giannoukakis N, Trucco M
Biotechniques 2003 Jul;35(1):122-45. -
A promoter genotype and oxidative stress potentially link resistin to human insulin resistance.
Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G.
Diabetes 2003 Jul;52(7):1611-8 -
Gene regulation of aldose-, aldehyde- and a renal specific oxido reductase (RSOR) in the pathobiology of diabetes mellitus.
Danesh FR, Wada J, Wallner EI, Sahai A, Srivastava SK, Kanwar YS
Current Medicinal Chemistry 2003 Aug;10(15):1399-406 -
Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy.
Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W
Nephrology, dialysis, transplantation 2003 Aug;18(8):1535-40. -
MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis.
Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, Gonzalez S, Lopez-Larrea C.
Human Immunology 2003 Aug;64(8):816-822 -
Making sense of diabetes: cultural models, gender and individual adjustment to Type 2 diabetes in a Mexican community
Raminta Daniulaityte
Social Science & Medicine 2004; 59;1899–1912 -
Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes
Y. Park
Diabetes Research and Clinical Practice 2004 December, Vol 66, Supplement 1, Pg S19-S25 -
Prevention of type 2 diabetes mellitus from the viewpoint of genetics
Kyong Soo Park
Diabetes Research and Clinical Practice 2004 December, Vol 66, Supplement 1, Pg S33-S35 -
Gene Therapy Progress and Prospects: Gene therapy for diabetes mellitus
V Yechoor and L Chan
Gene Therapy 2005 January, Vol 12, No. 2, Pages 101-107 -
Impact of a Diabetes Prevention Program on Body Size, Physical Activity, and Diet Among Kanien'kehá:ka (Mohawk) Children 6 to 11 Years Old: 8-Year Results From the Kahnawake Schools Diabetes Prevention Project
Gilles Paradis, Lucie Lévesque, Ann C. Macaulay, Margaret Cargo, Alex McComber, Rhonda Kirby, Olivier Receveur, Natalie Kishchuk, and Louise Potvin
Pediatrics 2005; 115: 333-339.